Orexo AB (FRA:C5G)
€ 1.078 0.203 (23.2%) Market Cap: 37.46 Mil Enterprise Value: 78.99 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Q3 2021 Orexo AB Earnings Call Transcript

Nov 03, 2021 / 12:00PM GMT
Release Date Price: €3.12 (-3.28%)
Operator

Welcome to the Orexo's Q3 report for 2021. (Operator Instructions) Today, I am pleased to present our first speaker, CEO, Nikolaj Sorensen. Please begin your meeting.

Nikolaj SÃ;rensen;publ;President;CEO
Orexo AB

¸ - ()-&

Thank you very much, and welcome to this third quarter presentation for Orexo. Some of you will notice, we've been following us for a while, and we have chosen a new format for our presentation, and I hope it's something that you will appreciate. I will start on Page #2 with the agenda. So I will talk a little about the key achievements during the third quarter. Then we -- I will continue talking about the U.S. pharma progress. But I know based on the number of questions we have received prior to the call during the morning, but there's a lot of focus on because of therapeutics. So we have invited Dennis Urbaniak, who will join us from Chicago, where we have a kickoff meeting with part of our feed force or the sales of modia. And Dennis, as you know, he is responsible for digital

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot